taurolidine has been researched along with Neutropenia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aguilar-Guisado, M; Albasanz-Puig, A; Arnan, M; Berbel, D; Carratalà, J; Cisneros, JM; Gudiol, C; Laporte-Amargós, J; Martín-Gandul, C; Montero, I; Nicolae, S; Perayre, M; Riera, J; Royo-Cebrecos, C; Sánchez-Ortega, I; Sureda, A; Tebe, C | 1 |
| Aguilar-Guisado, M; Arnan, M; Berbel, D; Carratalà, J; Cisneros-Herreros, JM; Encuentra, M; Gudiol, C; Martín-Gandul, C; Montero, I; Nicolae, S; Perayre, M; Royo-Cebrecos, C | 1 |
2 trial(s) available for taurolidine and Neutropenia
| Article | Year |
|---|---|
A Randomized, Double-Blind, Placebo-Controlled Trial (TAURCAT Study) of Citrate Lock Solution for Prevention of Endoluminal Central Venous Catheter Infection in Neutropenic Hematological Patients.
Topics: Catheter-Related Infections; Catheterization, Central Venous; Central Venous Catheters; Citrates; Double-Blind Method; Female; Hematologic Neoplasms; Humans; Incidence; Male; Middle Aged; Neutropenia; Pharmaceutical Solutions; Prospective Studies; Taurine; Thiadiazines | 2020 |
Administration of taurolidine-citrate lock solution for prevention of central venous catheter infection in adult neutropenic haematological patients: a randomised, double-blinded, placebo-controlled trial (TAURCAT).
Topics: Anti-Infective Agents; Antineoplastic Agents; Catheter-Related Infections; Catheterization, Central Venous; Catheters, Indwelling; Central Venous Catheters; Citrates; Device Removal; Double-Blind Method; Equivalence Trials as Topic; Hematologic Neoplasms; Humans; Multicenter Studies as Topic; Neutropenia; Prospective Studies; Risk Factors; Spain; Taurine; Thiadiazines; Time Factors; Treatment Outcome | 2018 |